Clinical Trial Update: Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical trial evaluating pidnarulex (CX-5461) in patients with metastatic solid cancers, currently recruiting to assess safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Cancer

Drugs mentioned

• Pidnarulex (CX-5461)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Malignant Solid Neoplasm | Phase 1 | Status: RECRUITING